The Europe Aspiration & Biopsy Needles Market would witness Market growth of 5.5% CAGR during the forecast period (2022-2028).
In recent years, the needles used during aspiration and biopsy procedures have gained popularity. The industry is competitive due to the existence of numerous Market players, all of whom are competing to increase their presence in the aspiration and biopsy needles Market . Many growth-promoting factors are driving the Market , including a growing desire for minimally invasive surgeries, greater cancer awareness campaigns by global health organizations and governments, and rising cancer incidences.
Biopsies on the breast entail the extraction of tissues and cells from areas of the breast that are susceptible to diseases like cancer. Under a microscope, these tissues and cells are checked for the possibility of malignancy. A core needle biopsy is when a hollow needle is introduced into the breast with the aim of removing tissue samples. A core needle biopsy is performed to detect any lumps, masses, or other worrisome locations seen via imaging testing or a mammogram. Biopsy, which uses fine needles, also involves the removal of cells that could be malignant tumors in the breast. As compared to the needle used in core needle biopsy, the needle used for fine needle biopsy is thinner.
Liquid biopsy is the focus of research and development in the Europe Liquid Biopsy Market for cancer diagnosis. Extensive clinical studies are being conducted by Market participants and research organizations in order to build a sensitive liquid biopsy platform. Grail, a biotechnology startup based in the United States, raised $1 billion in venture money in May 2018 and launched early breast cancer studies with 120,000 patients. CancerSEEK was developed by Johns Hopkins University researchers in January 2018. More than 1,000 patients with non - metastatic stage I to III ovarian, stomach, liver, pancreatic, esophagus, lung, colorectal, and breast cancer were included in the study. In the upcoming years, large-scale liquid biopsy research targeted at facilitating early cancer diagnosis may drive the Market .
The Germany Market dominated the Europe Aspiration & Biopsy Needles Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $86.6 million by 2028. The UK Market is estimated to grow at a CAGR of 4.6% during (2022 - 2028). Additionally, The France Market would experience a CAGR of 6.3% during (2022 - 2028).
Based on Product Type, the Market is segmented into Biopsy Needles and Aspiration Needles. Based on Procedure, the Market is segmented into Image-guided and Nonimage-guided. Based on Image-guided Type, the Market is segmented into Ultrasound-guided, CT-guided, MRI-guided, Stereotactic, and Others. Based on End User, the Market is segmented into Hospitals & surgical centers, Diagnostic Clinics & pathology laboratories, Ambulatory care centers, Research & Academic Institutes. Based on Application, the Market is segmented into Tumor/ Cancer Applications, Wound Applications, and Others. Based on Tumor/ Cancer Applications Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Aspiration & Biopsy Needles Market Size will Hit $1.3 Billion by 2028, at a CAGR of 6.1%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Johnson & Johnson, Merit Medical Systems, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ConMed Corporation, Olympus Corporation, Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product Type
By Procedure
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 